Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN News Highlights: Back to Item

Flush with Cash, Versartis and Diartis Focus on Drugs Based on Amunix’ XTEN Technology

Firms are separately developing once-monthly growth hormone and exenatide drugs using half-life extension platform.



Click here to log in or to register for free.

You will be taken back to your selected item after log-in/registration.

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll